6-29486851-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_052967.2(MAS1L):c.1052G>A(p.Gly351Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000403 in 1,614,104 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_052967.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MAS1L | NM_052967.2 | c.1052G>A | p.Gly351Asp | missense_variant | 1/1 | ENST00000377127.4 | NP_443199.1 | |
LOC105375008 | XR_007059916.1 | n.394+1688C>T | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MAS1L | ENST00000377127.4 | c.1052G>A | p.Gly351Asp | missense_variant | 1/1 | 6 | NM_052967.2 | ENSP00000366331.3 | ||
ENSG00000289203 | ENST00000688607.1 | n.1583+656G>A | intron_variant |
Frequencies
GnomAD3 genomes AF: 0.000263 AC: 40AN: 152102Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000955 AC: 24AN: 251372Hom.: 0 AF XY: 0.0000883 AC XY: 12AN XY: 135846
GnomAD4 exome AF: 0.0000171 AC: 25AN: 1461884Hom.: 0 Cov.: 32 AF XY: 0.0000165 AC XY: 12AN XY: 727240
GnomAD4 genome AF: 0.000263 AC: 40AN: 152220Hom.: 0 Cov.: 32 AF XY: 0.000376 AC XY: 28AN XY: 74422
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 10, 2022 | The c.1052G>A (p.G351D) alteration is located in exon 1 (coding exon 1) of the MAS1L gene. This alteration results from a G to A substitution at nucleotide position 1052, causing the glycine (G) at amino acid position 351 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at